Biotech giant Bayer plans to distribute mustard greens that have been genetically altered to make them less bitter to grocery stores across the country.

A trial vaccine has succeeded in generating low levels of antibodies needed to target HIV. It’s a first but much-needed step toward preventing infection.

Platelets help blood clot, but they have a short shelf life. With blood in short supply, synthetic platelets could help meet demand.

Elon Musk says Neuralink’s first human trial subject can control a computer mouse with their brain, but some researchers are frustrated by a lack of information about the study.